This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Roche Sequencing Solutions, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Li Tai Fang - Innovator in Cancer Genomics
Introduction
Li Tai Fang is a prominent inventor based in San Francisco, CA, known for his significant contributions to the field of cancer genomics. His innovative work focuses on detecting cancer driver genes and pathways, which is crucial for understanding the genetic basis of cancer.
Latest Patents
Li Tai Fang holds a patent for a method of detecting significantly mutated genes and pathways in a cancer cohort. This patent describes techniques that take into account the heterogeneous mutational context within cancer samples. The invention utilizes a statistical model of gene-specific mutation rate distribution to identify gene/pathway enrichment and differentiate between tumor suppressors and oncogenes based on mutation patterns.
Career Highlights
Throughout his career, Li Tai Fang has worked with notable companies such as Roche Sequencing Solutions, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to develop and refine his expertise in cancer research and genomic technologies.
Collaborations
Li Tai Fang has collaborated with talented individuals in the field, including Yao Fu and Aparna Chhibber, who have contributed to his research endeavors.
Conclusion
Li Tai Fang's innovative work in cancer genomics and his patent for detecting cancer driver genes highlight his significant impact on the field. His contributions continue to advance our understanding of cancer biology and improve diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile